| Bioactivity | Brentuximab is a chimeric antibody targeting CD30. Brentuximab can be used for the research of emerging targeted therapies[1]. |
| Name | Brentuximab |
| CAS | 2088770-90-3 |
| Appearance | Liquid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Oh Y, et al. Part II: Prognosis and management. J Am Acad Dermatol. 2021 Nov;85(5):1093-1106. |